Carisma Therapeutics Ownership | Who Owns Carisma Therapeutics?
Carisma Therapeutics Ownership Summary
Carisma Therapeutics is owned by 9.53% institutional investors, 27.76% insiders, and 62.71% retail investors. Merck is the largest institutional shareholder, holding 3.53% of CARM shares.
CARM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Carisma Therapeutics | 9.53% | 27.76% | 62.71% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Merck | 1.47M | 3.53% | $576.92K |
| Aju ib investment | 718.33K | 1.72% | $281.30K |
| Blackrock funding, inc. /de | 336.79K | 0.81% | $131.89K |
| Gts securities | 50.12K | 0.12% | $19.65K |
| Empowered funds | 30.99K | 0.07% | $12.13K |
| Two sigma securities | 17.95K | 0.04% | $7.03K |
| Bank & trust | 525.00 | 0.00% | $206.00 |
| Org partners | 200.00 | 0.00% | $80.00 |
| Raymond james financial | 75.00 | 0.00% | $29.00 |
| Harbour investments | 37.00 | 0.00% | $14.00 |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Aju ib investment | 718.33K | 0.31% | $281.30K |
| Merck | 1.47M | 0.27% | $576.92K |
| Two sigma securities | 17.95K | 0.00% | $7.03K |
| Gts securities | 50.12K | 0.00% | $19.65K |
| Bank & trust | 525.00 | 0.00% | $206.00 |
| Empowered funds | 30.99K | 0.00% | $12.13K |
| Harbour investments | 37.00 | - | $14.00 |
| Org partners | 200.00 | - | $80.00 |
| Virtu financial | - | - | - |
| Baader bank aktiengesellschaft | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Gts securities | 50.12K | 0.00% | 50.12K |
| Two sigma securities | 17.95K | 0.00% | 6.34K |
| Raymond james financial | 75.00 | - | 75.00 |
| Org partners | 200.00 | - | - |
| National bank of canada /fi/ | 50.00 | - | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Barclays | - | - | -549.30K |
| Millennium management | - | - | -120.16K |
| Blackrock funding, inc. /de | 336.79K | - | -70.09K |
| Hrt financial lp | - | - | -36.90K |
| Stratos wealth partners | - | - | -22.20K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Gts securities | 50.12K | 0.00% | 50.12K | $19.65K |
| Raymond james financial | 75.00 | - | 75.00 | $29.00 |
Sold Out
| Holder | Change |
|---|---|
| Citigroup | -10.00 |
| Peoples bank/ks | -250.00 |
| Federated hermes | -5.63K |
| Tower research capital llc (trc) | -7.83K |
| Stonex group | -10.73K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 34 | -2.86% | 3,982,439 | -2.93% | 9 | 9.78% | 10 | -28.57% | 6 | - |
| Mar 31, 2025 | 36 | - | 5,576,157 | 16.58% | 13 | 10.13% | 14 | -6.67% | 6 | -14.29% |
| Dec 31, 2024 | 38 | 2.70% | 4,888,967 | -6.07% | 11 | 7.50% | 16 | 45.45% | 7 | -41.67% |
| Sep 30, 2024 | 37 | -24.49% | 5,205,020 | -14.78% | 12 | 5.80% | 11 | -60.71% | 12 | -7.69% |
| Jun 30, 2024 | 49 | -2.00% | 6,107,691 | -28.20% | 14 | 3.40% | 28 | 55.56% | 13 | -31.58% |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
CARM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools